These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Damadzic R; Shuangshoti S; Giblen G; Herman MM Acta Neuropathol; 2002 May; 103(5):488-94. PubMed ID: 11935265 [TBL] [Abstract][Full Text] [Related]
4. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Regenold WT; Phatak P; Marano CM; Gearhart L; Viens CH; Hisley KC Psychiatry Res; 2007 Jun; 151(3):179-88. PubMed ID: 17433451 [TBL] [Abstract][Full Text] [Related]
5. Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Hamazaki K; Hamazaki T; Inadera H Psychiatry Res; 2013 Nov; 210(1):346-50. PubMed ID: 23731984 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder. Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564 [TBL] [Abstract][Full Text] [Related]
7. Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder. Thomsen MS; Weyn A; Mikkelsen JD Bipolar Disord; 2011; 13(7-8):701-7. PubMed ID: 22085484 [TBL] [Abstract][Full Text] [Related]
8. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Beneyto M; Meador-Woodruff JH Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238 [TBL] [Abstract][Full Text] [Related]
9. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Ghose S; Weickert CS; Colvin SM; Coyle JT; Herman MM; Hyde TM; Kleinman JE Neuropsychopharmacology; 2004 Jan; 29(1):117-25. PubMed ID: 14560319 [TBL] [Abstract][Full Text] [Related]
10. Distribution and levels of 5-HT Veldman ER; Svedberg MM; Svenningsson P; Lundberg J Eur Neuropsychopharmacol; 2017 May; 27(5):504-514. PubMed ID: 28318898 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients. Gilabert-Juan J; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Nácher J Neurosci Lett; 2012 Nov; 530(1):97-102. PubMed ID: 23022470 [TBL] [Abstract][Full Text] [Related]
12. Bipolar II disorder is associated with thinning of prefrontal and temporal cortices involved in affect regulation. Elvsåshagen T; Westlye LT; Bøen E; Hol PK; Andreassen OA; Boye B; Malt UF Bipolar Disord; 2013 Dec; 15(8):855-64. PubMed ID: 23980618 [TBL] [Abstract][Full Text] [Related]
13. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Beneyto M; Kristiansen LV; Oni-Orisan A; McCullumsmith RE; Meador-Woodruff JH Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517 [TBL] [Abstract][Full Text] [Related]
14. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Uezato A; Meador-Woodruff JH; McCullumsmith RE Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996 [TBL] [Abstract][Full Text] [Related]
15. Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia. Ghose S; Chin R; Gallegos A; Roberts R; Coyle J; Tamminga C Schizophr Res; 2009 Jun; 111(1-3):131-7. PubMed ID: 19403271 [TBL] [Abstract][Full Text] [Related]
16. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798 [TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Tian SY; Wang JF; Bezchlibnyk YB; Young LT Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155 [TBL] [Abstract][Full Text] [Related]
18. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289 [TBL] [Abstract][Full Text] [Related]
19. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder. Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649 [TBL] [Abstract][Full Text] [Related]
20. Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Jin CY; Anichtchik O; Panula P Br J Pharmacol; 2009 May; 157(1):118-29. PubMed ID: 19413576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]